[A randomized double-blinded placebo-controlled clinical trial of minodronate tablet in postmenopausal Chinese women with osteoporosis].

Chunxia Peng、Rong Tian、Ling Li、Yuanyuan Zhu、Shouzhuo Li、Senqi Ye、Long He、Juan Niu

2022PubMedBiochemistry, Genetics and Molecular Biology被引 2

摘要

Minodronate is effective and safe in the treatment of postmenopausal osteoporosis without severe side effects.

引用本文（GB/T 7714）

Chunxia Peng, Rong Tian, Ling Li, 等. [A randomized double-blinded placebo-controlled clinical trial of minodronate tablet in postmenopausal Chinese women with osteoporosis].[J]. PubMed, 2022.

引文网络

参考文献与被引分析加载中…

DOI：https://doi.org/10.3760/cma.j.cn112141-20220220-00108

本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。